Amplification of Mdmx and overexpression of MDM2 contribute to mammary carcinogenesis by substituting for p53 mutations

Differences in breast carcinoma immunohistochemical subtypes between immigrant Arab and European women

(2014) Fanny Preat et al.   Diagnostic Pathology

Significance of ERβ expression in different molecular subtypes of breast cancer

(2014) Liying Guo et al.   Diagnostic Pathology

The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients

(2013) Qingli Zhang et al.   Diagnostic Pathology

Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients

(2013) Liang Liu et al.   Diagnostic Pathology

Expression of microRNA-497 and its prognostic significance in human breast cancer

(2013) Shaohua Wang et al.   Diagnostic Pathology

Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes

(2013) Hongxia Cheng et al.   Diagnostic Pathology

MdmX regulates transformation and chromosomal stability in p53-deficient cells

(2011) Zdenka Matijasevic et al.   CELL CYCLE

A comparison between p53 accumulation determined by immunohistochemistry andTP53mutations as prognostic variables in tumours from breast cancer patients

(2008) Jan Alsner et al.   ACTA ONCOLOGICA

Genomic instability and proliferative activity as risk factors for distant metastases in breast cancer

(2008) L Li et al.   BRITISH JOURNAL OF CANCER

High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 (MDM4) as an Amplification Target Exclusive of MDM2 and TP53

(2008) A. Veerakumarasivam et al.   CLINICAL CANCER RESEARCH